Privacy disclosure: Your personal information is completely confidential and will only be used to determine eligibility for the CeliacShield Study. This survey is HIPAA-compliant and designed to protect your personal health information.
Thank you for your interest in participating. This screening survey determines preliminary eligibility and is not a guarantee of enrollment.
Enrollment in the study involves attending five in-person visits at the study site in Rochester, Minnesota over the course of 14 weeks. Participants will be asked to complete a daily electronic symptoms diary. You will be given gluten in the form of breadcrumbs (approximately one-half slice of bread) once daily at your evening meal for six consecutive weeks, during which time you will also take either the investigational medication or placebo.
All study supplies are provided at no cost. Qualified participants may be reimbursed for study participation, including transportation costs. Should you decide to complete the questionnaire, a study staff member will contact you with further information about your qualification status.